Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79472 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Voriconazole Related Compound C (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone)
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C10H7F2N3OCouleur et forme :Pale Yellow SolidMasse moléculaire :223.05572Terbinafine Related Compound C ((2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C21H25N·HClCouleur et forme :White Off-White PowderMasse moléculaire :327.17538Valproic Acid Related Compound K (2-Ethyl-2-methylpentanoic acid)
CAS :Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFormule :C8H16O2Couleur et forme :Clear Yellow Oily LiquidMasse moléculaire :144.11503Diclofenac Sodium
CAS :Aromatic amino-acids and their esters,other than thoseFormule :C14H11Cl2NO2·NaCouleur et forme :PowderMasse moléculaire :318.00645Zolmitriptan R-Isomer
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H21N3O2Couleur et forme :Yellow PowderMasse moléculaire :287.16338Cilostazol Related Compound B (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C20H25N5O2Couleur et forme :White Brown PowderMasse moléculaire :367.20083Amitriptyline Related Compound B (5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C20H25NOCouleur et forme :White PowderMasse moléculaire :295.19361Argatroban Related Compound B (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C15H28N6O5·2HClCouleur et forme :Off-White PowderMasse moléculaire :444.16547Amlodipine Related Compound D (3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxoisoindolin-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C28H27ClN2O7Couleur et forme :Off-White PowderMasse moléculaire :538.15068Poloxamer Solid
CAS :Nonionic surface-active agents,aromatic or modified aromatic,whether or not put up for retail saleFormule :HO(C2H4O)a(C3H6O)b(C2H4O)aHCouleur et forme :White Cream PowderMasse moléculaire :304.2931Furosemide Related Compound A (2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid)
CAS :Sulfonamides, nesoiFormule :C12H11ClN2O5SCouleur et forme :White Off-White PowderMasse moléculaire :330.00772Azacitidine Related Compound A (4-Amino-1,3,5-triazin-2(1H)-one)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C3H4N4OCouleur et forme :White Off-White PowderMasse moléculaire :112.03851Latanoprost Related Compound B (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate)
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C26H40O5Couleur et forme :LiquidMasse moléculaire :432.28757Salicylic Acid Related Compound A (4-hydroxybenzoic acid)
CAS :Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc nesoiFormule :C7H6O3Couleur et forme :White PowderMasse moléculaire :138.03169Adapalene Related Compound B (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C29H30O3Couleur et forme :PowderMasse moléculaire :426.21949Zolmitriptan Related Compound B ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H23N3OCouleur et forme :White SolidMasse moléculaire :261.18411Propantheline Bromide Related Compound A (9-Hydroxypropantheline bromide)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C23H30BrNO4Couleur et forme :White PowderMasse moléculaire :463.13582Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C11H15NO4Couleur et forme :White PowderMasse moléculaire :225.10011Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H10ClNOCouleur et forme :Light Yellow PowderMasse moléculaire :243.694-Hydrazinylbenzenesulfonamide Hydrochloride
CAS :Sulfonamides, nesoiFormule :C6H9N3O2S·HClCouleur et forme :Light Yellow Beige Crystalline PowderMasse moléculaire :223.01823Aripiprazole Related Compound H (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one)
Lactams, nesoiFormule :C27H35Cl2N3O3Couleur et forme :White Pale Yellow Crystalline PowderMasse moléculaire :519.20555Haloperidol Related Compound A (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]butyrophenone)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H36Cl2N2O3Couleur et forme :White PowderMasse moléculaire :566.2103Mafenide Related Compound A (4-Formylbenzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C7H7NO3SCouleur et forme :White PowderMasse moléculaire :185.2N-Ethylpiperazine
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C6H14N2Couleur et forme :Colorless LiquidMasse moléculaire :114.1157Phenyltoloxamine Related Compound A (2-(2-Benzylphenoxy)ethylmethylamine hydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C16H19NO·HClCouleur et forme :White Light Yellow PowderMasse moléculaire :241.14666Dimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C8H9ClN4O2Couleur et forme :White Off-White PowderMasse moléculaire :228.0414Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H18N2O3SCouleur et forme :PowderMasse moléculaire :270.103811-Mononitroglycerin
CAS :Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormule :C3H7NO5Couleur et forme :Clear Colorless LiquidMasse moléculaire :137.03242Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C7H11NO6P2Couleur et forme :White Crystalline PowderMasse moléculaire :267.11Phenytoin Related Compound B (2,2-Diphenyl-2-ureidoacetic acid)
CAS :Ureines and their derivatives; salts thereofFormule :C15H14N2O3Couleur et forme :White PowderMasse moléculaire :270.10044Ziprasidone Related Compound F (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H22ClN4NaO2S·H2OCouleur et forme :White Off-White SolidMasse moléculaire :470.11553Nateglinide Related Compound A (trans-4-isopropylcyclohexanecarboxylic acid)
CAS :Cyclanic, cyclenic or cycloterpenic monocarboxylic acidFormule :C10H18O2Couleur et forme :White CrystalsMasse moléculaire :170.13068Trisalicylic Acid
CAS :Esters of salicylic acid and its salts not elsewhere specified or includedFormule :C21H14O7Couleur et forme :White PowderMasse moléculaire :378.07395Hyoscyamine Related Compound A (Norhyoscyamine Sulfate)
Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :(C16H21NO3)2H2SO4Couleur et forme :White PowderMasse moléculaire :648.77Pancuronium Bromide Related Compound C (1,1'-(3α-acetoxy-17β-hydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C33H58N2O3·2BrCouleur et forme :White Crystalline PowderMasse moléculaire :530.44474Ethyl Benzoate
CAS :Benzoic acid, its salts and estersFormule :C9H10O2Couleur et forme :Colorless LiquidMasse moléculaire :150.06808Sulindac Related Compound C ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C20H17FO2SCouleur et forme :Yellow PowderMasse moléculaire :340.09333Fluorouracil Related Compound F (2-Ethoxy-5-fluoropyrimidin-4(1H)-one)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C6H7FN2O2Couleur et forme :White Off-White PowderMasse moléculaire :158.04916Bisacodyl Related Compound A (4,4'-(Pyridin-2-ylmethylene)diphenol)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C18H15NO2Couleur et forme :White Crystalline PowderMasse moléculaire :277.11028Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C10H16O4SCouleur et forme :White PowderMasse moléculaire :232.07693Desogestrel Related Compound D (13-Ethyl-11-methylenegon-4-en-17-one)
CAS :Cyclanic, cyclenic or cycloterpenic ketones without other oxygen function not elsewhere specified or includedFormule :C20H28OCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :284.21402Torsemide Related Compound A (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide)
CAS :Sulfonamides, nesoiFormule :C12H13N3O2SCouleur et forme :Off-White Fine PowderMasse moléculaire :263.072853-O-Methylmethyldopa
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C11H15NO4·H2OCouleur et forme :White PowderMasse moléculaire :225.10011Bis(2-ethylhexyl)maleate (Maleic acid, bis(2-ethylhexyl)ester)
CAS :Maleic acid not in us note 3 section 6Formule :C20H36O4Couleur et forme :LiquidMasse moléculaire :340.51Travoprost
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C26H35F3O6Couleur et forme :Colorless Clear Pale Yellow LiquidMasse moléculaire :500.23857Piroxicam Related Compound J (Methyl 4-hydroxy-2-methyl-2H-benzothiazine-3-carboxylate 1,1-dioxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H11NO5SCouleur et forme :White Off-White Fine PowderMasse moléculaire :269.03579Palonosetron Related Compound B ((3S)-3-(1-Oxo-5,6-dihydro-1H-benzo[de]isoquinolin-2(4H)-yl)quinuclidine 1-oxide)
CAS :Lactams not elsewhere specified or includedFormule :C19H22N2O2Couleur et forme :Yellow PowderMasse moléculaire :310.16813Xanthanoic Acid
CAS :Aromatic heterocyclic pesticides with oxygen hetero-atom(s) only, nesoiFormule :C14H10O3Couleur et forme :White PowderMasse moléculaire :226.06299Budesonide Related Compound E (16α,17-[butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C25H32O6Couleur et forme :PowderMasse moléculaire :428.21989Clomipramine Related Compound C (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C19H21ClN2·HClCouleur et forme :Yellow PowderMasse moléculaire :312.13933Triclosan Related Compounds Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :Colorless Clear LiquidDipyridamole Related Compound B (2,2',2'',2''',2'''',2'''''-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H40N8O6Couleur et forme :Green Yellow PowderMasse moléculaire :524.30708Amantadine Related Compound A (1-Chloroadamantane)
CAS :Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormule :C10H15ClCouleur et forme :White CrystalsMasse moléculaire :170.08623Palonosetron Related Compound A ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide)
CAS :Lactams not elsewhere specified or includedFormule :C19H24N2O2Couleur et forme :White SolidMasse moléculaire :312.18378Sulfamethoxazole Related Compound B (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C16H16N4O5S2Couleur et forme :Off-White White PowderMasse moléculaire :408.05621Theophylline Related Compound D (N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate)
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C6H10N4O·HCl·H2OCouleur et forme :Off-White Light Brown PowderMasse moléculaire :208.0727Nicotine Related Compound F (3-(pyrrolidin-2-yl)pyridine)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C9H12N2Couleur et forme :Colorless Translucent Oily LiquidMasse moléculaire :148.10005Xylometazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-2,6-dimethylphenyl]acetamide)
CAS :Sulfonamides used as drugsFormule :C16H26N2OCouleur et forme :Off-White SolidMasse moléculaire :262.20451Clopidogrel Related Compound C (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H16ClNO2S·H2SO4Couleur et forme :White PowderMasse moléculaire :321.05903Methylene Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate)
CAS :Lactones nesoiFormule :C25H36O5Couleur et forme :White PowderMasse moléculaire :416.25627Metformin Related Compound C (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C5H10N6Couleur et forme :White Off-White PowderMasse moléculaire :154.09669Tetraxetan Related Compound A (2,2',2""-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid)
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C18H32N4O8Couleur et forme :Off-White PowderMasse moléculaire :432.22201Norfloxacin Related Compound H (7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C19H22FN3O5Couleur et forme :Off-White PowderMasse moléculaire :391.15435R-Methotrexate (Sodium (R)-2-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C20H20N8Na2O5Couleur et forme :Yellow Dark Yellow PowderMasse moléculaire :498.1352Metaraminol Related Compound B (2-Amino-1-[3-(benzyloxy)phenyl]propan-1-ol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C15H19NO2Couleur et forme :White SolidMasse moléculaire :245.14158Ticlopidine Related Compound A (4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C7H7NOSCouleur et forme :White Off-White PowderMasse moléculaire :153.02484Nimodipine Related Compound B (bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H26N2O8Couleur et forme :Pale Yellow Crystalline PowderMasse moléculaire :434.16892Dextromethorphan Related Compound C (3-Methoxy-17-methyl-9 α,13 α,14 α-morphinan-10-one)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C18H23NO2Couleur et forme :Light Yellow SolidMasse moléculaire :285.17288Nevirapine Related Compound A (5,11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C14H14N4OCouleur et forme :Light Yellow Off-White Crystalline PowderMasse moléculaire :254.11676Norscopolamine ((1R ,2R ,4S ,5S ,7s )-3-Oxa-9-azatricyclo[3.3.1.0^2,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate)
CAS :Aromatic or modified aromatic heterocyclic compounds with nitrogen hetero atom(s) only, except acridine, indole and carbazoleFormule :C16H19NO4Couleur et forme :White Off-White PowderMasse moléculaire :289.13141Ethinyl Estradiol Related Compound B (19-Nor-17α-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol monohydrate)
CAS :Estrogens and progestinsFormule :C20H22O2·H2OCouleur et forme :White Yellow PowderMasse moléculaire :312.17254Bupivacaine Related Compound B N-(2,6-Dimethylphenyl)piperidine-2-carboxamide Hydrochloride
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H20N2O·HClCouleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :232.15756Phenylephrine Related Compound C (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C9H11NO2·HClCouleur et forme :Yellow Yellow Green PowderMasse moléculaire :201.05566Orphenadrine Related Compound F (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C18H23NO·C6H8O7Couleur et forme :White PowderMasse moléculaire :461.20497Allopurinol Related Compound D (Ethyl 5-amino-1H-pyrazole-4-carboxylate)
CAS :Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure nesoiFormule :C6H9N3O2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :155.06948Chloroquine Related Compound G (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFormule :C18H26ClN3O·H2SO4Couleur et forme :Yellow PowderMasse moléculaire :433.14382Terazosin Related Compound A (6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C14H19N5O2·2HClCouleur et forme :White PowderMasse moléculaire :289.15387Megestrol Acetate Related Compound H
CAS :Esters of acetic acid not elsewhere specified or includedFormule :C25H34O4Couleur et forme :PowderMasse moléculaire :398.24571Isoflurane Related Compound A (1-Chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether)
CAS :Ethers of monohydric alcohols, nesoiFormule :C3HCl2F5OCouleur et forme :Clear Colorless LiquidMasse moléculaire :217.93246Mefloquine Related Compound A (threo-mefloquine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H16F6N2O·HClCouleur et forme :White PowderMasse moléculaire :378.11668Dobutamine Related Compound C (N-(3,4-Dimethoxyphenethyl)-4-(4-methoxyphenyl)butan-2-amine hydrochloride)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormule :C21H29NO3·HClCouleur et forme :White PowderMasse moléculaire :379.19142Bendamustine Related Compound G (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H20ClN3O2S·HClCouleur et forme :Off-White Light Brown SolidMasse moléculaire :389.07315Flunixin Related Compound B (2-Methyl-3-(trifluoromethyl)aniline)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C8H8F3NCouleur et forme :White Off-White PowderMasse moléculaire :175.06088Ioversol Related Compound B (N,N'-Bis(2,3-dihydroxypropyl)-5-{[N-(2-hydroxyethyl)amino]-2-oxoethoxy}-2,4,6-triiodoisophthalamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C18H24I3N3O9Couleur et forme :White Off-White GranularMasse moléculaire :806.86467Ranolazine Related Compound B (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H31N3O3Couleur et forme :White PowderMasse moléculaire :397.23654m-Aminophenol
CAS :Amino-naphthols and other amino-phenols, their ethers aFormule :C6H7NOCouleur et forme :White Pale Yellow PowderMasse moléculaire :109.12 g/molThimerosal Related Compound A (2,2'-Disulfanediyldibenzoic acid)
CAS :Other aromatic organoFormule :C14H10O4S2Couleur et forme :PowderMasse moléculaire :306.00205Metformin Related Compound B (1-Methylbiguanide hydrochloride)
CAS :Non-aromatic imines and their derivatives; salts thereof, nesoiFormule :C3H9N5·HClCouleur et forme :White PowderMasse moléculaire :115.0858Roflumilast Related Compound E (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H14BrClF2N2O3Couleur et forme :White Beige PowderMasse moléculaire :445.98444Albuterol Related Compound F (4-[2-(tert-Butylamino)-1-ethoxyethyl]-2-(hydroxymethyl)phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C15H25NO3Couleur et forme :White SolidMasse moléculaire :267.18344Orphenadrine Related Compound B (N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium chloride; also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride)
CAS :Quaternary ammonium salts and hydroxides, whether or not chemically defined, otherFormule :C20H28ClNOCouleur et forme :White Off-White PowderMasse moléculaire :333.18594N-Demethylazithromycin
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C37H70N2O12Couleur et forme :White PowderMasse moléculaire :734.49288Sulindac Related Compound A ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C20H17FO3SCouleur et forme :Yellow PowderMasse moléculaire :356.08824Gadoteridol Related Compound B (Gadolinium(III) 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate dihydrate)
CAS :Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, excluding cerium compounds, nesoiFormule :C14H23GdN4O6·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :501.08587Abacavir Related Compound C ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C11H12ClN5O·HClCouleur et forme :White Cream PowderMasse moléculaire :265.07304Estazolam Related Compound A (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H11Cl2N3OCouleur et forme :Light Yellow Off-White White Crystalline PowderMasse moléculaire :331.02792Lansoprazole Related Compound A (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H14F3N3O3SCouleur et forme :White Crystalline PowderMasse moléculaire :385.0708Fenoldopam Related Compound A (N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride)
Aromatic or modified aromatic drugs with nitrogen heterFormule :C17H18ClNO3·HClCouleur et forme :PowderMasse moléculaire :319.09752
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
![Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604643.webp&w=3840&q=75)
![Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1718063.webp&w=3840&q=75)
